Description
Survodutide 5mg (BI 456906) – Dual GLP-1/Glucagon Receptor Agonist Research Peptide Survodutide 5mg (development code BI 456906 , also written BI-456906 / SURVO) is an investigational synthetic peptide characterised as a dual GLP-1/glucagon receptor agonist , supplied as a white…
Reference specifications
- Supports glucose and metabolic regulation research
- Investigated for energy balance in research models
- Among the most-studied metabolic peptides




